Health
Medical
Consulting
Syneos Health
$42.459876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$42.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.69 (1.65%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Syneos Health and other stocks, options, ETFs, and crypto commission-free!
About
Syneos Health, Inc. engages in the provision of Morrisville. It operates though the Clinical Solutions and Commercial Solutions segments. Read More The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded on August 13, 2010 and is headquartered in Morrisville, NC.
Employees
24,000
Headquarters
Morrisville, North Carolina
Founded
2010
Market Cap
4.33B
Price-Earnings Ratio
242.65
Dividend Yield
0.00
Average Volume
680.64K
High Today
$42.78
Low Today
$41.97
Open Price
$41.97
Volume
146.22K
52 Week High
$56.34
52 Week Low
$36.27
Collections
Health
Medical
Consulting
Business Services
2014 IPO
US
North America
News
Yahoo FinanceMay 10
Syneos' Q1 Earnings Miss Estimates, Revenues In Line
Syneos Health Inc. SYNH posted first-quarter 2019 adjusted earnings per share (EPS) of 59 cents, which missed the Zacks Consensus Estimate by 1.7%. However, the metric rose 7.3% from the year-ago tally. Reported net loss per share came in at 29 cents, wider than the loss of 24 cents in the year-ago quarter. Revenues in Detail Service revenues in the quarter totaled $1.12 billion. The top line increased 5.8% year over year but was on par with the Zacks Consensus Estimate. Per management, revenue growth ac...
Seeking AlphaMay 9
Syneos Health, Inc. (SYNH) CEO Alistair MacDonald on Q1 2019 Results - Earnings Call Transcript
Syneos Health, Inc. (NASDAQ:SYNH) Q1 2019 Earnings Conference Call May 9, 2019 8:00 AM ET Company Participants Ronnie Speight - Senior Vice President, Investor Relations Alistair MacDonald - Chief Executive Officer Jason Meggs - Chief Financial Officer Michelle Keefe - President, Commercial Solutions Paul Colvin - President, Clinical Solutions Conference Call Participants David Windley - Jefferies LLC Tycho Peterson - J.P. Morgan Chase & Co. Robert Jones - Goldman Sachs Jack Meehan - Barclays Cap...
Price Paid on Robinhood
6% Lower
Right Now
52 Week Low
$36.27
Average Price Paid
$45.06
52 Week High
$56.34
Earnings
$0.51
$0.66
$0.80
$0.95
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, Pre-Market